Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-002413
Accepted
2025-07-31 00:15:26
Documents
1
Effectiveness Date
2025-07-30

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-25-002413.txt   1724
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-288769 | Film No.: 251169104
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)